Newsletter
0
Project CBD Newsletter: Hemp Flour in Bread, Myrcene for Brain Injury, Cannabinoid Biosynthesis via Fungi, CBD/THC for Neuropathy, and CBD/THCV for Colitis
0

This week’s newsletter covers the latest plant medicine research, including hemp flour’s nutritional benefits in baking, myrcene’s neuroprotective ...

0
Project CBD Newsletter: Older Cannabis Users Show Superior Cognitive Performance, Industry Reacts to Federal Hemp THC Ban, and the Linguistic Evolution of Cannabis Culture
0

This week’s newsletter covers surprising findings on cannabis use and cognitive performance in older adults, the industry and policy fallout from the ...

0
Project CBD Newsletter: New seed ban risks driving cannabis genetics underground, terpenes activate cannabinoid receptors, psychedelics and capitalism, mushroom edible safety concerns, and cannabinoids for skin and prostate cancer
0

This week’s newsletter covers a federal cannabis seed ban threatening to push genetics underground, the science of terpenes activating cannabinoid ...

0
Project CBD Newsletter: Trump Signs Executive Order to Reclassify Cannabis as Schedule III, Hemp Enforcement Challenges, Cannabinoids and Ovarian Cancer, Sleep Research, and More
0

This week’s newsletter covers Trump’s executive order directing cannabis rescheduling to Schedule III, federal enforcement challenges around ...

0
Project CBD Newsletter: Trump Signs Order to Reclassify Cannabis as Schedule III, FDA/DEA Hemp Enforcement Challenges, Microdosing THC and CBD for Alzheimer’s, and More
0

This week’s newsletter covers cannabis rescheduling, hemp regulation enforcement hurdles, promising cannabinoid research for Alzheimer’s disease and ...

0
Project CBD Newsletter: Cannabis Rescheduling Uncertainty, Psychedelic Polypharmacy, Psilocybin and Fear Extinction, Ontological Shock, and Cancer-Related Depression
0

This week’s newsletter covers the uncertain fate of cannabis rescheduling under the Trump administration, along with new research on psychedelic ...

0
Project CBD Newsletter: How Psychedelics Inspire Scientific Insight, CBD Research on Pain, Inflammation, Alzheimer’s, Cancer, and Heart Disease
0

This week’s newsletter explores how psychedelic experiences can fuel scientific breakthroughs, alongside a roundup of recent research on CBD’s ...

0
Project CBD Newsletter: Cannabis for Treatment-Resistant Depression, CBD Cardiovascular Benefits, Acidic Cannabinoids, Traumatic Brain Injury, and CBD-THC Interactions in Caffeinated Beverages
0

This week’s newsletter covers new research on cannabis for treatment-resistant depression, CBD’s potential in cardiovascular health and traumatic ...

0
Project CBD Newsletter: Microdosing Psilocybin and Creativity, Non-Hallucinogenic Psychoplastogens, Neuroplasticity, Psychedelic Product Integrity, and Psilocybin for Chronic Pain
0

This week’s newsletter covers the latest research and journalism on plant medicine, including a landmark study on psilocybin microdosing and ...

0
Project CBD Newsletter: Cannabis Use Linked to Greater Cognitive Performance in Seniors, CBD Research Round-Up, and Semi-Synthetic Cannabinoid Challenges
0

This week’s newsletter covers new findings on cannabis and cognitive performance in older adults, the challenges posed by semi-synthetic ...

0
Project CBD Newsletter: MDMA and Memory Impairment, Ibogaine Safety, Psychedelic Industry Ethics, CBD Liver Study, Prenatal Cannabis Exposure, Migraine Relief, and CBD for Autism
0

This week’s newsletter covers MDMA’s potential effects on memory, safety concerns around ibogaine, ethical questions in the psychedelic investment ...

0
Project CBD Newsletter: Synthetic Cannabinoids in Hemp Products, CBD and Melanoma, Cannabis Roots, Neuroprotection, Antimicrobial Research, and More
0

This week’s newsletter covers a major analysis exposing synthetic cannabinoids in online hemp products, plus a research round-up on CBD’s potential ...

Daily Deals
Logo
Compare items
  • Total (0)
Compare
0
Shopping cart